A clinical metric referring to the degree to which androgen receptors within target tissues are occupied by circulating androgens, primarily testosterone and dihydrotestosterone (DHT). This level is a more functional indicator of androgenic activity than merely measuring total or free hormone concentrations in the serum. High saturation levels imply maximal biological effect, while low levels suggest suboptimal tissue response, irrespective of adequate serum levels.
Origin
The terminology originates from pharmacology and receptor kinetics, applying the concept of “Saturation” from ligand-receptor binding studies to the specific class of “Androgen” hormones. This clinical descriptor is essential for understanding the actual biological impact of androgen therapy or endogenous production.
Mechanism
The mechanism centers on the binding affinity and concentration of androgens at the nuclear and cytoplasmic receptor sites within cells. Once an androgen binds, the hormone-receptor complex translocates to the nucleus to regulate gene transcription, mediating the hormone’s biological effects on muscle, bone, and brain tissue. Saturation occurs when nearly all available receptors are occupied, signifying a plateau in potential cellular response to further increases in circulating hormone.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.